Point-of-care testing for HbA1c "is superior for identifying unknown chronic hyperglycemia, particularly prediabetes" versus standard diabetes screening tests, a study found. POCT HbA1c was compared with standard testing, and it identified significantly more patients with undiagnosed diabetes or prediabetes, 10% and 53%, respectively, versus 8% and 33%.
POCT HbA1C superior for identifying unknown diabetes, prediabetes
Sign up for AANP SmartBrief
News for nurse practitioners
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.